Drop size of commercial glaucoma medications.
暂无分享,去创建一个
[1] M. Kass. Non-compliance to ocular therapy , 1978 .
[2] J. Robinson,et al. Lacrimal and instilled fluid dynamics in rabbit eyes. , 1973, Journal of pharmaceutical sciences.
[3] I. Leopold. Ocular cholinesterase and cholinesterase inhibitors. , 1961, American journal of ophthalmology.
[4] G. Petursson,et al. Treatment of glaucoma using minidrops of clonidine. , 1984, Archives of ophthalmology.
[5] Davidson Si. Systemic effects of eye drops , 1974 .
[6] T. F. Patton,et al. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs. , 1978, American journal of ophthalmology.
[7] M. Kass,et al. Patient administration of eyedrops: observation. Part II. , 1982, Annals of ophthalmology.
[8] J. Robinson,et al. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. , 1976, Journal of pharmaceutical sciences.
[9] J W Shell,et al. Pharmacokinetics of topically applied ophthalmic drugs. , 1982, Survey of ophthalmology.
[10] R. Brown,et al. Creating smaller eyedrops by reducing eyedropper tip dimensions. , 1985, American journal of ophthalmology.
[11] J. Bonica,et al. SYSTEMIC EFFECTS OF EPINEPHRINE APPLIED TOPICALLY TO THE EYE , 1966 .
[12] F. Fraunfelder,et al. Ocular beta-blockers and systemic effects. , 1984, Archives of internal medicine.